SciPharm SARL
🇱🇺Luxembourg
Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH)
Phase 3
Completed
- Conditions
- Non-operable Chronic Thromboembolic Pulmonary Hypertension
- Interventions
- First Posted Date
- 2011-08-15
- Last Posted Date
- 2022-06-07
- Lead Sponsor
- SciPharm SÃ RL
- Target Recruit Count
- 105
- Registration Number
- NCT01416636
- Locations
- 🇦🇹
Krankenhaus der Elisabethinen, Linz, Austria
🇨🇿II. internà klinika Všeobecná fakultnà nemocnice, Prague, Czechia
🇵🇱NZOZ Europejskie Centrum Zdrowia Otwock, Otwock, Poland
© Copyright 2025. All Rights Reserved by MedPath